$MRNA is a good mover, presenting a case to buy on the morning panic dip which happens almost (keyword almost) religiously around 10:45-10:55am. Probably 1 out of 5 days, this morning dip buy setup doesn't work, in which case I would just cut the trade short.
I missed this guy when I jumped on MRNA and INO earlier this week. Just trying to pin this one down a bit, coronavirus stocks are wild and fun :). For FOMO stocks, typical support and resistance horizontal lines aren't as predictive and you should instead look to the Volume Profile. Support should be right around the POC, which is $40. It should slide down to...
Many people are interested in the question, will the shares of Moderna (MRNA) go even higher or not? After all, not so long ago, they were able to show growth of more than 300% in a few months! I will tell you this - if you prefer systematic trading and open your trades on signals, it is not clear at the moment (so we chose a neutral or observational idea). But...
Nothing too serious here, just an observer on this one. One of my biggest regrets, I pumped money into INO instead of MRNA when they were both cheap when the smart play was covering the field. Noob move... alas, there's always another stock to chase. Anyway, here's a decent stock architecture for anyone playing this. Basically I'm just hoping it dips super low...
nice broadening formation here.. can rip to 81 if it gets 72
I know the news about Moderna is hype right now but technicals are showing a bearish divergence from the RSI. Based on the "Lazy Elliott" Forecast, if you're going to assume this plot to be an impulse wave, wave 3 from this perspective might be complete already. One way to verify is if the price closes below the 161.8% level, it might signal the start of wave...
First off, please don't take anything I say seriously or as financial advice. As always, this is on opinion based basis. Moderna's Covid19 vaccine for mRNA-1273 is reaching Phase 2 clinical trails by the FDA which is further ahead than most of its small competitors and bio-pharmaceutical corporations. As always, you see the big giant crushing the small one. This...
One of the leaders on cracking Vacine Jumping through all the Hoops Dr Fauci says it looks good plenty of funding like 400 mill plus and heaps in the bank pulling out all the stops to be first.
watch out for the breakout above the triangle
MRNA is in completing the continuation pattern and with some volume it will breakout
Hi traders, Quite a good trading day on Wednesday, I ended up around BE for the day but I felt generally in good control. One small improvement could've been made in early exit of my first trade. My Trades: 1) ALC - SHORT @56.94, I made a small mistake of not exiting earlier as ALC wasn't reacting at all to the market going down again. -1.06 2) MRNA - LONG...
Gilead Sciences , Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. The company's products include Biktarvy, Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Atripla, and Truvada for the treatment of human immunodeficiency...
What is XBi? XBI provides exposure to one of the broadest portfolios among US biotech ETFs. The fund equal-weights its portfolio, which in turn emphasizes small- and micro-caps and greatly reduces single-name risk. Thus, the weighted-average market cap is much smaller than some competitors. Unlike other funds in this segment, XBI is a pure biotech play, with...
Hi traders, The other day I posted a reverse entry which happened to be a loser as well, but I told you it typically pays off. On Friday I got to prove it when WDC didn't react the way I planned and that got me thinking if the other direction wasn't a better idea... and it was! The Trades: 1) WDC - SHORT @38.73 - terrible fill at the break of 39, in hindsight I...
engages in the development of transformative medicines based on messenger ribonucleic acid. Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. GOOD OF START of the company of may...
Bullish: Every week since the low has closed green except this week. Bearish: The last week of each month have been particularly bearish since January. The overwhelming bull trend that's taken place over the past few weeks have been disorienting. My bias is now leaning neutral. I will consider the downtrend on hold if the monthly closes above the 17th of April...